(Total Views: 398)
Posted On: 01/04/2020 8:01:49 AM
Post# of 145247
Imbruvica pulled in $4.1 billion in U.S. sales (2018)
Imbruvica treats only B cell cancers with much smaller patient populations then ours can treat.
So a $21 billion BO of Cytodyn would seem to be quite the underbid.
Imbruvica treats only B cell cancers with much smaller patient populations then ours can treat.
So a $21 billion BO of Cytodyn would seem to be quite the underbid.
(0)
(0)